Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jeanine M L Roodhart

13PUBLICATIONS

62CO-AUTHORS

Molecular targetsPredictive and prognostic markersModels of care and place of birthCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Apr 07, 2026

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Maarten A Huismans, Eelke H Gort, Lisa T van der Heijden

|Jan 09, 2026

Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study.

Carmen Rubio-Alarcón, Andrew Georgiadis, Ingrid A Franken

|Sep 22, 2025

Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer.

Lidwien P Smabers, G Emerens Wensink, Carla S Verissimo

|Sep 08, 2025

A comparison by mismatch repair status of real-world characteristics and outcomes in patients with stage II/III rectal cancer in the Netherlands.

Renee A Lunenberg, Ingrid A Franken, Frederieke H van der Baan

|Apr 17, 2025

Reply to: Putting IDEA's Results Into Practice: Practicality Should Rule Complexity in Stage III Colon Cancer.

Ingrid A Franken, Frederieke H van der Baan, Jeanine M L Roodhart

|Mar 13, 2025

Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohort.

Sietske C M W van Nassau, Koen Zwart, Frederieke H van der Baan

Pageof 3

Frequent Collaborators

7 joint publications

Miriam Koopman

3 joint publications

G Emerens Wensink

3 joint publications

Ingrid A Franken

3 joint publications

Maarten A Huismans

2 joint publications

Geraldine R Vink

2 joint publications

Wilhelmina M U van Grevenstein

2 joint publications

Petur Snaebjornsson

2 joint publications

Lidwien P Smabers

2 joint publications

Onno Kranenburg

2 joint publications

Koen Zwart

Frequent Collaborators

7 joint publications

Miriam Koopman

3 joint publications

G Emerens Wensink

3 joint publications

Ingrid A Franken

3 joint publications

Maarten A Huismans

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on : Mar 14, 2019

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

See more related videos

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on : Mar 14, 2019

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

See more related videos